Access 55 Verified Employees Profiles for Sab BioUnlock Free Contacts Now
About
A clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing fully-human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D)